Trosman, Julia
Weldon, Christine
Kircher, Sheetal
Gradishar, William
Benson, Al III
Article History
First Online: 11 February 2019
Compliance with Ethical Standards
:
: Julia Trosman has received consulting fees (paid to Center for Business Models in Healthcare, Glencoe, IL) from Genentech.Christine Weldon has received consulting fees (paid to Center for Business Models in Healthcare, Glencoe, IL) from Genentech.Sheetal Kircher declares that she has no conflict of interest.William Gradishar declares that he has no conflict of interest.Al Benson III has received research funding from Novartis, Acerta Pharma, Celgene, Advanced Accelerator Applications, Merck Sharpe & Dohme, Taiho Pharmaceuticals, Bristol-Myers Squibb, and MedImmune/AstraZeneca; has received consulting/advisory fees from Bristol-Myers Squibb, Guardant Health, Eli Lilly & Company, Exelixis, Purdue Pharma, Xcenda, inVentiv Health, Inc., Axio, Genentech, Bayer, Merck, Rafael Pharmaceuticals, and Terumo; has served as a Data Monitoring Committee member for Astellas, Infinity Pharmaceuticals, and Merck Sharpe & Dohme; has given CME presentations for Harborside, meeting presentations for the National Comprehensive Cancer Network; and has served on an Editorial Board for Emron.
: This article does not contain any studies with human or animal subjects performed by any of the authors.